Page last updated: 2024-10-21

normetanephrine and Bone Loss, Osteoclastic

normetanephrine has been researched along with Bone Loss, Osteoclastic in 1 studies

Normetanephrine: A methylated metabolite of norepinephrine that is excreted in the urine and found in certain tissues. It is a marker for tumors.

Research Excerpts

ExcerptRelevanceReference
"018), in a dose-response manner across increasing urinary normetanephrine quartile categories (P for trend = 0."2.87Higher sympathetic activity as a risk factor for skeletal deterioration in pheochromocytoma. ( Kim, BJ; Kim, JS; Koh, JM; Kwak, MK; Lee, SH, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, BJ1
Kwak, MK1
Kim, JS1
Lee, SH1
Koh, JM1

Trials

1 trial available for normetanephrine and Bone Loss, Osteoclastic

ArticleYear
Higher sympathetic activity as a risk factor for skeletal deterioration in pheochromocytoma.
    Bone, 2018, Volume: 116

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Bone and Bones; Bone Density; Bone Resorption; Cancellous Bone

2018